Genetic Medicine : Division Home | Department of Medicine

Advances in molecular biology and human genetics, coupled with the completion of the Human Genome Project and the increasing power of quantitative genetics to identify disease susceptibility genes, are contributing to a revolution in the practice of medicine. In the 21st century, practicing physicians will focus more on defining genetically determined disease susceptibility in individual patients. This strategy will be used to prevent, modify, and treat a wide array of common disorders that have unique heritable risk factors such as hypertension, obesity, diabetes, arthrosclerosis, and cancer.

The Division of Genetic Medicine provides an academic environment enabling researchers to explore new relationships between disease susceptibility and human genetics. The Division of Genetic Medicine was established to host both research and clinical research programs focused on the genetic basis of health and disease. Equipped with state-of-the-art research tools and facilities, our faculty members are advancing knowledge of the common genetic determinants of cancer, congenital neuropathies, and heart disease. The Division faculty work jointly with the Vanderbilt-Ingram Cancer Center to support the Hereditary Cancer Clinic for treating patients and families who have an inherited predisposition to various malignancies.

Genetic differences in humans at the molecular level not only contribute to the disease process but also significantly impact an individuals ability to respond optimally to drug therapy. Vanderbilt is a pioneer in precisely identifying genetic differences between patients and making rational treatment decisions at the bedside.

See the article here:

Genetic Medicine : Division Home | Department of Medicine

Genetic Medicine | List of High Impact Articles | PPts …

Genetic medicine is the integration and application of genomic technologies allows biomedical researchers and clinicians to collect data from large study population and to understand disease and genetic bases of drug response. It includes genome structure, functional genomics, epigenomics, genome scale population genomics, systems analysis, pharmacogenomics and proteomics. The Division of Genetic Medicine provides an academic environment enabling researchers to explore new relationships between disease susceptibility and human genetics. The Division of Genetic Medicine was established to host both research and clinical research programs focused on the genetic basis of health and disease. Equipped with state-of-the-art research tools and facilities, our faculty members are advancing knowledge of the common genetic determinants of cancer, congenital neuropathies, and heart disease.

Related Journals of Genetic Medicine

Cellular & Molecular Medicine, Translational Biomedicine, Biochemistry & Molecular Biology Journal, Cellular & Molecular Medicine, Electronic Journal of Biology, Molecular Enzymology and Drug Targets, Journal of Applied Genetics, Journal of Medical Genetics, Genetics in Medicine, Journal of Anti-Aging Medicine, Reproductive Medicine and Biology, Romanian journal of internal medicine

Follow this link:

Genetic Medicine | List of High Impact Articles | PPts ...

Genetic Medicine University of Chicago Department of …

Yoav Gilad, PhD

Chief, Section of Genetic Medicine

University of ChicagoDepartment of Medicine

The Section of Genetic Medicine was created over 10 years ago to both build research infrastructure in genetics within the Department of Medicine and to focus translational efforts related to genetics. As a result, the Section of Genetic Medicine is shaping the future of precision medicine with very active and successful research programs focused on the quantitative genetics, systems biology and genomics, and bioinformatics and computational biology. The Section provides extremely valuable collaborations with investigators in the Department of Medicine who are seeking to develop new and more powerful ways to identify genetic risk factors for common, complex disorders with almost immediate clinical application.

The Section of Genetic Medicine continues to shape the future of personalized medicine with successful research programs focused on the quantitative genetic and genomic science. The Section provides extremely valuable collaborations with investigators in the Department of Medicine who are seeking to develop new and more powerful ways to identify genetic risk factors for common, complex disorders with almost immediate clinical application.

The Section of Genetic Medicine conducts impactful investigations focused on quantitative genetics, systems biology and genomics, bioinformatics and computational biology. Some recent highlights include:

Read more here:

Genetic Medicine University of Chicago Department of ...

Genetic Counseling – School of Medicine | University of …

What does it mean to be a genetic counseling student?

At the University of South Carolina it means you become part of the team from day one: an engaged learner in our genetics center.You'll have an experienced faculty who are open door mentors in your preparation for this career.

You'll have access in the classroom and in the clinic to the geneticist and genetic counselor faculty in our clinical rotation network oftwelve genetic centers. The world of genetic counseling will unfold for you in two very busy years, preparing you to take on the dozens of roles open to genetic counselors today.

You can meet our faculty and learn more about the genetic counseling profession in our Genetic Counseling Online Course.

Rigorous coursework, community service, challenging clinical rotations and a research-based thesis will provide opportunity for tremendous professional growth.

We've been perfecting our curriculum formore than 30 years to connect the knowledge with the skills youll need as a genetic counselor. Our reputation for excellence is known at home and abroad. We carefully review more than 140 applications per year to select thenine students who will graduate from the School of Medicine Genetic Counseling Program. Our alumni are our proudest accomplishment and work in the best genetic centers throughout the country. They build on our foundation to achieve goals in clinical care, education, research and industry beyond what we imagined.

First in the Southeast and tenth in the nation, we are one of49 accredited programs in the United States. We have graduatedmore than 200 genetic counselors, many of whom are leading the profession today. Weve received highly acclaimed Commendations for Excellence from the South Carolina Commission of Higher Education.

TheGenetic Counseling Program at the University of South Carolina School of Medicineis accredited by the Accreditation Council for Genetic Counseling, Inc., 7918 Jones Branch Drive, Ste. 300, McLean, VA 22102. Telephone: (703) 506 - 7667

You'll have the chance to form lifelong partnerships with our core and clinical rotation faculty. Build your professional network with geneticists and genetic counselors throughout the Southeast.

One of our program's greatest assets is our alumni. This dedicated group regularly teaches and mentors our students,serves on our advisory board, and raises money for our endowment.You'll enjoy the instant connection when meeting other USC Genetic Counseling graduates. As a student, you'll benefit from the alumni networkand all they have to offer you. Check out our Facebook group.

The future of genetic counseling is yours. Invest your talents ... you'll be amazed at the deeply satisfying opportunities to serve. We welcome your interestand look forward tohelping you take the next step on your path to becoming a genetic counselor.

Continued here:

Genetic Counseling - School of Medicine | University of ...

Genetic Medicine Clinic at UW Medical Center

Directions to CHDD from Main Information Desk at UWMCThe Patient Information Desk on the main (3rd Floor) of UWMC has detailed directions and a map to CHDD and may be able to provide an escort. From the Information Desk take the Pacific Elevators to the 1st Floor of the hospital. Walk through the Plaza Caf and exit the back glass doors of the hospital. CHDD is the four story brick building directly across the street. Check in at the reception desk on the main (2nd Floor) of CHDD.

Access the lot from 15th Avenue N.E. Stop at gate house 6 to obtain a parking permit.

Look for CHDD- designated or UWMC disability parking stalls. Walk out of S1 at the east end and enter CHDD Clinic building. Patients can be dropped off at the CHDD entrance from which vehicles can return to S1 for parking. A cash payment of $15.00 is required upon entry. Please leave the permit on your dashboard. A partial discount voucher will be given at appointment check-in for patients or family members.

CHDD Parking Brochure (PDF)

Disability ParkingFor All CHDD patients and families with mobility parking needs, the closest parking is in the S1 Garage. Please request a disability placard at the gate house. A cash payment of $15.00 is required upon entry. Please leave the permit on your dashboard. A partial discount voucher will be given at appointment check-in for patients or family members. Valet parking is available at the main entrance of the Medical Center; wheelchairs and escort services are available from the Information Desk.

Valet ParkingValet parking service for patients and their visitors is located in front of the Medical Center, near the main entrance. Allow extra time if you choose to use valet parking.

From valet service, walk east to the main entrance of UWMC. The Information Desk has detailed directions and a map to CHDD and may be able to provide an escort.Triangle Parking GarageThe Triangle Parking Garage is located on N.E. Pacific Place, across the street from UW Medical Center. From Montlake Blvd., turn left onto N.E. Pacific Street and right onto N.E. Pacific Place. The Triangle Garage has a height restriction of 6 8. Allow extra time if you choose to use the Triangle Parking Garage.From the Triangle Garage, take the pedestrian tunnel to the front entrance of the UWMC. The Information Desk has detailed directions and a map to CHDD and may be able to provide an escort.

Surgery Pavilion Parking GarageThe Surgery Pavilion Parking Garage is accessed off of N.E. Pacific Street next to the Emergency Room entrance. The Surgery Pavilion has a height restriction of 9 6 on Level P1. Levels P2 & P3 (2nd & 3rd floor) have a height restriction of 6 7. Allow extra time if you choose to use the Surgery Pavilion Parking Garage.

From the Surgery Pavilion Parking Garage, take the elevator to the third floor. Walk across the pedestrian overpass to the main hospital building lobby. The Information Desk has detailed directions and a map to CHDD and may be able to provide an escort.Payment Rates for parking in S-1, Valet, Triangle, Surgery Pavilion:Patients parking in S-1 will need to pay $15 up front which will be partially reimbursed with validation upon exiting the parking lot (see rates for parking in link above). Credit/Debit cards will be reimbursed on the card, while patients paying cash will be given a cash reimbursement.

Getting to UW Medical Center

Read the rest here:

Genetic Medicine Clinic at UW Medical Center

Islands (miniseries) – Wikipedia

Islands is an American animated miniseries based on the show Adventure Time by Pendleton Ward. It aired as part of the show's eighth season on Cartoon Network from January 30, 2017, to February 2, 2017. Adventure Time follows the adventures of Finn (voiced by Jeremy Shada), a human boy, and his best friend and adoptive brother Jake (voiced by John DiMaggio), a dog with magical powers to change shape, grow and shrink at will. In this limited event series, Finn, Jake, BMO (voiced by Niki Yang) and Susan Strong (voiced by Jackie Buscarino) leave Ooo and voyage across the ocean to learn about Finn's origin. During their trip, they encounter various creatures, new friends, and several interesting islands. The trip culminates with a visit to Founder's Island, where Finn meets his biological mother, Minerva Campbell (voiced by Sharon Horgan), and discovers what happened to the remainder of the human race.

DVD cover

Islands is the second Adventure Time miniseries to have been produced, following Stakes, which aired in November 2015. Islands was preceded by the release of a graphic novel, which tied into the story and served as a prequel. The miniseries' story was developed by head writer Kent Osborne, series showrunner Adam Muto, story editor Jack Pendarvis, and staff writer Ashly Burch. Storyboard artists who worked on this miniseries include Sam Alden, Polly Guo, Seo Kim, Somvilay Xayaphone, Tom Herpich, Steve Wolfhard, Graham Falk, Pendleton Ward, Hanna K. Nystrm, Aleks Sennwald, Kent Osborne, and Adam Muto. Cole Sanchez and Elizabeth Ito served as the miniseries' supervising directors, and Sandra Lee served as art director. Islands was met with positive reviews, with many critics applauding how the miniseries further developed the show's characters. Additionally, the episode "Imaginary Resources" won a Primetime Emmy Award for Outstanding Individual Achievement in Animation at the 69th Primetime Creative Arts Emmy Awards in 2017. Islands was released on DVD on January 24, 2017.

Contents

A large robotic craft arrives searching for Finn. When Finn (voiced by Jeremy Shada) finally encounters it, Jake (voiced by John DiMaggio) destroys it with his fist. Princess Bubblegum (voiced by Hynden Walch) examines the wreckage and discovers its location of origin; this engenders in Finn a desire to discover the craft's creators. Finn thus resolves to travel across the sea from whence the craft came, but before leaving, he tells Fern (voiced by Hayden Ezzy) to stay and look after Ooo for him. Princess Bubblegum, Marceline (voiced by Olivia Olson) and Fern see Finn, Jake and Susan Strong (voiced by Jackie Buscarino) off on their voyage. Initially, the journey is easy and uneventful, but soon, Finn, Jake, and Susan encounter a sea dragon named Whipple (voiced by Josh Fadem), who turns out to be rather annoying. BMO (voiced by Niki Yang), who unbeknownst to the others was stowing away on their boat, angrily tells Whipple off, which causes the sea dragon to summon a storm and destroys their boat. This predicament forces Jake to use his magical powers and take on the shape of a boat for the rest to ride. Unfortunately, below the surface of the water, a species of jellyfish latches onto him, which causes Jake to begin hallucinating. Eventually, after much struggle, Finn and Susan are able to remove them, which causes the hallucinations to end. At this point, Jake complains about wanting to return home, but Finn reveals how important this trip is to him. Whipple overhears Finn's lament and begins to feel sorry for his actions; he then uses his powers to blow the group over the dangerous waters.

After an encounter with a mysterious colossus, Finn wakes up on an island where the weather drastically fluctuates. After meandering around for awhile, he eventually encounters an old lady named Alva (voiced by Helena Mattsson) who does not speak English. Alva invites Finn to her home and shows her home movies of other humans who have since presumably died. Later, Finn, Alva and her pet bear encounter Jake, who informs the group that he does not know the whereabouts of either BMO and Susan. Finn and Jake eventually head to a futuristic island where all of society has hooked themselves up to a virtual reality simulator. BMO is revealed to have become the heroic leader of the VR people, and he rules them along with his sidekick Vinny (voiced by Reggie Watts). Jake decides to go and destroy the generator powering the VR after BMO refuses to leave. Feeling bad for BMO, as well as the emaciated humans who emerge from the virtual reality simulator, Finn asks Jake to fix the generator, but BMO fixes it himself. BMO recognizes that if he remains behind, he will lose his friends, and so he, Finn, and Jake take a pod to the next island. It is on this stop that Finn, Jake and BMO find Susan, who begins to recall her long-forgotten past (as well as her adult-level intellect).

An extended flashback reveals Finn's origin, and what happened to the other humans. Roughly a thousand years prior to the main events of the series, a group of humansaided by Marcelinefled Ooo on a container ship (as seen in Stakes). They eventually settled on a secluded island chain far from the mainland. Over the next thousand years, their community thrived and developed into an advanced technological society. While it was a veritable utopia, there were those few who occasionally grew dissatisfied with their rigidly structured lives and attempted to flee the island; these "hiders" were in turn hunted down and returned by specially trained "seekers". It is revealed that Susan's real name is Kara, and that she was once a seeker in training. Kara was friends with a fellow human, Frieda (voiced by Jasika Nicole), who began expressing a desire to flee the safe albeit authoritarian island. This revelation causes Kara some discomfort, so she approaches Dr. Gross (voiced by Lennon Parham), the cybernetic human in charge of training seekers, asking if the humans can live off the island. Dr. Gross convinces her that the outside is dangerous and, to prevent her from fleeing, she controls Kara with a remote control. Now fully under Dr. Gross's control, Kara stops Frieda from leaving and drags her away crying. Back in the present, Susan tells Finn her real name and decides to take Finn to Founders Island so that he can be reunited with his mother, Minerva Campbell (voiced by Sharon Horgan).

The audience is then presented with a series of flashbacks detailing how Minerva, a doctor, met Finn's father Martin Mertins (voiced by Stephen Root) when he was hospitalized after it was mistakenly believed he was attempting to leave the island with a group of escapees. Martin and Minerva eventually fell in love and had Finn. However, when the group of attempted escapeesled by an elderly widow (voiced by Laraine Newman)sought revenge on Martin, he fled on a boat with Finn. His escape is thwarted by the colossusrevealed to be a security device that was created to protect Founders Island from outside threatswho attacks the craft. In the chaos, the pair are separated, leaving Finn to drift away. The group is arrested and Minerva is heartbroken over Martin and Finn's disappearance.

Back in the present, the group make it to Founders Island where humans have been living in relative peace. While Kara seeks to make amends with Frieda, Finn and Jake discover that the island is full of Minerva look-alike robots called "helpers". They are brought to the real Minervaa digitized consciousnesswhen Finn is identified as her son. Minerva reveals that she had Dr. Gross send Kara to retrieve Finn, but years had passed and Dr. Gross had accidentally released a deadly virus that was killing humans. Minerva had her essence uploaded into a computer, and then created the helpers to assist the human race. Now that she is with Finn, she expresses her desire that he stay permanently. Finn tries to convince Minerva that life off the island is not all bad, but Minerva thinks off-island life is dangerous. Finn then tries to convince the humans to leave, and they all rally alongside him. This causes Minerva to attempt to upload the consciousnesses of all the islands' inhabitants. To prevent this, Finn shares with her his memories of helping people, causing her to back down; she realizes that Ooo is not nearly a threat as she before believed. The humans all change their minds about leaving, except for Frieda. With Minerva's help, they defeat the colossus. Later, Kara and Frieda announce to Finn, Jake, and BMO that they have made amends and are leaving to have their own adventures. Finn has one final talk with Minerva through the VR headset, where the two embrace in the digital realm. Finn then returns to Ooo with Jake and BMO.

In February 2015 at an upfront regarding Cartoon Network's programming for the 2015 to 2016 television season, the network announced that Adventure Time would air a special miniseries entitled Stakes during the show's seventh season.[1] Comprising 8 episodes and airing in November 2015, this miniseries was a "phenomenal success, ranking as the #1 program in its time period with all key kids and boys audiences."[2] Prior to the airing of Stakes, head story writer Kent Osborne revealed that the show would likely produce several more miniseries,[3] and when it was announced that the series would end in 2018, the network's official press release stated that prior to the show's conclusion there would be "new episodes, mini-series, specials and more".[4]

According to TheSlanted, Cartoon Network took to "teas[ing]" information about the Islands miniseries immediately prior to its release.[5] For instance, in early November 2016, ComiXology announced that the graphic novel Islands would tie "into the huge Adventure Time: Islands television event, the mini-series airing on Cartoon Network this winter where Finn meets other humans and an important member of his family for the first time",[6] and later that month, an Amazon.com page for a pre-order of the Islands DVD was made available.[7][8] Similarly, on December 9, the official Adventure Time Tumblr account revealed that the miniseries would have a unique title sequence.[9] The announcements concerning the intro sequence, however, did not specifically explain what Islands was or when it would air.[10] Official announcements detailing the miniseries were finally released on December 12, 2016 via a press release distributed to various media outlets.[11]

Much like Stakes,[12] Islands has a unique title sequence that was designed just for the miniseries.[10] The new intro was storyboarded by Sam Alden and, much like the Stakes intro, was animated by Masaaki Yuasa's company Science SARU.[13] The sequence was previewed via Cartoon Network's Facebook page and the official Adventure Time Tumblr on December 12; at this time, the latter noted: "We were incredibly fortunate to have the fantastic staff of Science SARU animate [the] intro for [the] Islands miniseries. [Science SARU is] so good it's breathtaking."[9] Unlike the usual sequence which begins episodes of Adventure Time, the Islands intro adopts a nautical theme, and highlights the characters Finn, Jake, Susan Strong, and BMO; the theme itself is sung by Jeremy Shada, the voice actor for Finn.[13]

The miniseries' story was developed by head writer Kent Osborne, series showrunner Adam Muto, Jack Pendarvis, and Ashly Burch. Storyboard artists who worked on this miniseries include Sam Alden, Polly Guo, Seo Kim, Somvilay Xayaphone, Tom Herpich, Steve Wolfhard, Graham Falk, Pendleton Ward, Hanna K. Nystrm, Aleks Sennwald, Kent Osborne, and Adam Muto. Cole Sanchez and Elizabeth Ito served as the miniseries' supervising directors, and Sandra Lee served as art director.[nb 2]

The miniseries features vocal performances courtesy of the show's regular crew: Jeremy Shada (who voices Finn the Human), John DiMaggio (who portrays Jake the Dog), Hynden Walch (who voices Princess Bubblegum), and Olivia Olson (who plays Marceline the Vampire Queen). Niki Yang (who voices the sentient video game console BMO) and Jackie Buscarino (who lends her voice to the recurring character Susan Strong) also play an integral part in the miniseries.[14][15] The Adventure Time cast records their lines together as opposed to doing it individually. This is to capture more natural sounding dialogue among the characters. Hynden Walch has described these group session as akin to "doing a play readinga really, really out there play."[16]

The miniseries also features several guest actors lending their voices to various characters. Josh Fadem voices Whipple the sea-dragon, Helena Mattsson plays Alva, Reggie Watts voices Vinny, Jasika Nicole voices Freida, Livvy Stubenrauch plays young Kara/Susan, Sharon Horgan voices Finn's mother Minerva, and Laraine Newman lends her voice to the Widow.[15] Likewise, Lennon Parham and Stephen Root reprise their roles as Dr. Gross and Finn's father Martin, respectively. Root had previously appeared in a string of sixth-season episodes, beginning with "Escape from the Citadel", and Parham had last voiced her character in the seventh-season finale "Preboot".[17][18]

Islands aired as part of the show's eighth season on Cartoon Network from January 30, 2017, to February 2, 2017.[19] The miniseries made its international debut on Cartoon Network Australia on March 13, 2017.[20] In South Korea, Islands was edited into a feature film and then released theatrically on April 13, 2017.[21] Islands premiered on Cartoon Network UK on July 17, 2017 and concluded on July 20, 2017.[22]

The premiere episodes, "The Invitation"/"Whipple the Happy Dragon", were collectively watched by 1.20 million viewers and they both scored a 0.3 in the 18- to 49-year-old demographic according to Nielsen (Nielsen ratings are audience measurement systems that determine the audience size and composition of television programming in the United States); this means that 0.3 percent of all households with viewers aged 18 to 49 years old were watching television at the time of the episodes' airing.[23] This made the two episodes the most-watched installments of the series, in terms of viewers, since the seventh-season episode "Five Short Tables", which was viewed by 1.36 million viewers.[24] The miniseries' final two episodes, "Helpers" and "The Light Cloud", were collectively viewed by 1 million viewers, and scored a 0.27 in the 18- to 49-year-old demographic.[25]

Pre-release reviews of the miniseries were largely positive. Zack Smith of Newsarama gave the miniseries a largely positive review and called it "fan service writ large, one that will prove immensely satisfying for long-term fans of the series".[26] He applauded the way the string of episodes managed to start out with self-contained stories and move into a dense and emotional backstory. Tonally, Smith described the miniseries as possessing "the feel of an old-school post-apocalyptic SF sagaa journey through a devastated-but-wondrous world, with a sense of danger and mystery detached from the Land of Ooo."[26] Smith's only complaint was that "there's enough rich emotional material once the voyagers reach their destination that it feels like more time could be spent there".[26] Matthew Jacobson of The Spectrum wrote that "the story is masterful and imaginative" and that "if Islands is a litmus test, then the final season should be one heck of an adventure."[27]

Post-release reviews were also positive. Oliver Sava of The A.V. Club awarded the miniseries an "A" and wrote that it "can be seen as a summary of Adventure Time's growth over seven seasons, beginning with smaller, sillier tales that build to something much deeper."[28] He applauded how Islands "does fantastic work fleshing out supporting characters", specifically highlighting the show's nuanced and multidimensional portrayal of Martin, Dr. Gross, and Susan Strong.[28] He wrote that the miniseries' main story is "a powerful thesis statement cementing the show's overall message that adventure is at the core of personal discovery and fulfillment", and that this same story is "extremely relevant to the United States' current socio-political climate".[28] Dave Trumbore of Collider wrote that the string of episodes were "packed full of emotional resonance and deeply complex character relationships" and "dip[ped] into some emotionally difficult territory".[29] Trumbore was particularly complimentary towards the way the show managed to explicate Susan's character by giving her a compelling backstory. Ultimately, Trumbore wrote that while "Adventure Time: Islands succeeds in every aspect the series has become known for," it also "comes up short in familiar ways... Unfortunately, the style (and the duration) of Adventure Time episodes works against... delving into [the show's] mythology... so we'll just have to obsess over whatever glimpses we get and settle for watching this series again and again."[29]

In a highly complimentary review for The New Republic, Juliet Kleber wrote that "Islands does a dizzying amount of plot development in 80-something minutes."[30] Furthermore, she argued that "Finn's coming-of-age story and the exploration of the post-apocalyptic plotline" as featured in the miniseries "are handled just as deftly as any other subjectwith fun and a tinge of sorrow."[30] Zach Blumenfeld of Paste Magazine gave Islands a slightly more mixed, albeit still positive, review. He complimented the philosophical musing of the miniseries, which he argued "takes on shades of Black Mirror and existentialism to cast a critical eye on technology and the human spirit."[31] Blumenfeld wrote:

Islands [...] [gives] us a world in which incredibly advanced bioengineering and cybernetics have kept humans alive and ensconced in relative comfort. But the twist is that the very scientific drive to innovate and develop these technologies is precisely what damned our species in the first place. [...] What Islands ends up delivering, therefore, is the most harrowing answer to Fermi's famous paradox: Intelligent life will inevitably destroy itself.[31]

With this being said, he felt that episodes such as "Whipple the Happy Dragon" and "Mysterious Island" took time away from the main story, compacting Finn's emotional reaction to Founder's Island, which resulted in "relative emotional emptiness".[31]

Common Sense Media awarded the Islands miniseries with "The Common Sense Seal", calling it a "beautiful animated miniseries [that] explores a deep backstory."[32] The episode "Imaginary Resources" won a Primetime Emmy Award for Outstanding Individual Achievement in Animation at the 69th Primetime Creative Arts Emmy Awards in 2017.[33][34]

Warner Home Video released the entire miniseries digitally and on DVD on January 24, 2017.[7] This marked the second time that Adventure Time episodes had been released on home media before officially airing on Cartoon Network (the first instance being the release of the episode "Princess Day" on the DVD of the same name on July 29, 2014).[5][38]

In October 2016, it was announced that the stand-alone comic book, Islands, written by series' storyline writer Ashly Burch would function as a prequel to the miniseries.[6] The book was released on December 6, 2016.[40]

Directing clarifications

Explanatory notes

Read the original:

Islands (miniseries) - Wikipedia

The Hawaiian Islands | Hawaii.com

The Hawaiian Islands | Hawaii.com Aloha! We've updated our Privacy Policy and Terms of Service. Please click Accept if you're okay with these updates. Accept You're currently on: Home The Hawaiian Islands-Pick an Island-OahuMauiKauaiBig IslandLanaiMolokai Aloha, e komo mai

The Hawaiian Islands are one of the most geographically isolated places on earth, over 2,400 miles and nearly 4,000 km to the closest landmass, which is California, USA. Born of a volcanic hotspot rising from the sea floor of the Pacific Ocean, the Hawaiian archipelago formed nearly 75 million years ago, with the eldest islands of the chain long since eroded and submerged beneath the seas surface to the northwest and the youngest of the islands still forming beneath the seas surface to the south east.

This unique history of formation and isolation has given rise to breathtaking and extraordinary wonders. Perfect white sand beaches, abundant reefs, towering waterfalls, lush valleys, snow-capped mountains and fiery hot volcanic cauldrons captivate the hearts of those who visit as well as those who call this beautiful place home. A special culture has evolved from the unique natural environment of these islands. Native Hawaiians are the host culture here, and the values of Aloha have laid the foundation for the Hawaii we have today. Since the 1700s, peoples of various cultures have been arriving on these shores, bringing their foods, their music and their ways of life.

Today Hawaii is a bold showcase for farm-to-table fusion cuisine, culturally conscious fashion and innovation. Visitors will find themselves spoiled for options between romantic boutique getaways and family friendly five star resorts. High-end retailers have put Hawaii on the map of world-class shopping destinations, and Hawaiis passionate chefs have created a foodie frenzy here. As far forward as Hawaii has evolved, those looking for a walk back in time can still find Old Hawaii tucked away off the beaten paths. And the ancient stories still exist in the lovely hula hands of dancers who have given themselves as keepers of the culture.

Saturday, Mar. 09, 2019, 6:43:00 AM HST | Current Conditions: 69.1 Mostly Cloudy | Weather data provided by Weather Underground

Read the rest here:

The Hawaiian Islands | Hawaii.com

Genetic Variant Interpretation Tool | University of …

To aid our variant interpretation process, we created an openly-available online tool to efficiently classify variants based on the evidence categories outlined in the article: Richards, et al. Standards and guidelines for the interpretation of sequence variants. 2015. This site displays the evidence categories and descriptions from Table 3 and Table 4 with simple checkboxes for selecting appropriate criteria. The site then incorporates the algorithm in Table 5 to automatically assign the pathogenicity or benign impact based on the selected evidence categories. Since our process often requires analyzing multiple variants per patient, we have also allowed the option of aggregating each variant into an exportable table at the foot of the website for easy documentation of the variant review process for our records. Although this tool is based on the ACMG/AMP Standards and Guidelines, it is not affiliated with ACMG, AMP, or any of the authors of the publication.

_ PVS1 null variant (nonsense, frameshift, canonical 1 or 2 splice sites, initiation codon, single or multiexon deletion) in a gene where LOF is a known mechanism of disease

_ PS1 Same amino acid change as a previously established pathogenic variant regardless of nucleotide change_ PS2 De novo (both maternity and paternity confirmed) in a patient with the disease and no family history_ PS3 Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product_ PS4 The prevalence of the variant in affected individuals is significantly increased compared with the prevalence in controls_ PP1 (Strong evidence) Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease

_ PM1 Located in a mutational hot spot and/or critical and well-established functional domain (e.g., active site of an enzyme) without benign variation_ PM2 Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium_ PM3 For recessive disorders, detected in trans with a pathogenic variant_ PM4 Protein length changes as a result of in-frame deletions/insertions in a nonrepeat region or stop-loss variants_ PM5 Novel missense change at an amino acid residue where a different missense change determined to be pathogenic has been seen before_ PM6 Assumed de novo, but without confirmation of paternity and maternity_ PP1 (Moderate evidence) Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease

_ PP1 Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease_ PP2 Missense variant in a gene that has a low rate of benign missense variation and in which missense variants are a common mechanism of disease_ PP3 Multiple lines of computational evidence support a deleterious effect on the gene or gene product (conservation, evolutionary, splicing impact, etc.)_ PP4 Patients phenotype or family history is highly specific for a disease with a single genetic etiology_ PP5 Reputable source recently reports variant as pathogenic, but the evidence is not available to the laboratory to perform an independent evaluation

_ BP1 Missense variant in a gene for which primarily truncating variants are known to cause disease_ BP2 Observed in trans with a pathogenic variant for a fully penetrant dominant gene/disorder or observed in cis with a pathogenic variant in any inheritance pattern_ BP3 In-frame deletions/insertions in a repetitive region without a known function_ BP4 Multiple lines of computational evidence suggest no impact on gene or gene product (conservation, evolutionary, splicing impact, etc.)_ BP5 Variant found in a case with an alternate molecular basis for disease_ BP6 Reputable source recently reports variant as benign, but the evidence is not available to the laboratory to perform an independent evaluation_ BP7 A synonymous (silent) variant for which splicing prediction algorithms predict no impact to the splice consensus sequence nor the creation of a new splice site AND the nucleotide is not highly conserved

_ BS1 Allele frequency is greater than expected for disorder_ BS2 Observed in a healthy adult individual for a recessive (homozygous), dominant (heterozygous), or X-linked (hemizygous) disorder, with full penetrance expected at an early age_ BS3 Well-established in vitro or in vivo functional studies show no damaging effect on protein function or splicing_ BS4 Lack of segregation in affected members of a family

_ BA1 Allele frequency is >5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium

_ Sequencing artifact as determined by depth, quality, or other previously reviewed data

Download Table as CSV

Please note that the text of the variant evidence has been pulled directly from Richards, et al. Genet Med. 2015 May;17(5). This site does not claim authorship of any of the variant evidence descriptions.

This tool is based on the published ACMG/AMP Standards and Guidelines [Genet Med (2015)]. Anyone using this tool should be familiar with that publication. Individuals or institutions choosing to use this tool for clinical variant classification purposes assume legal responsibility for the consequences of its use. The authors make no warranty, express or implied, nor assume any legal liability or responsibility for any purpose for which the tool is used.

Please cite the following when using this tool in publications: Kleinberger J, Maloney KA, Pollin TI, Jeng LJ. An openly available online toolfor implementing the ACMG/AMP standards and guidelines for the interpretation of sequence variants. Genet Med. 2016 Mar 17. doi: 10.1038/gim.2016.13. [Epub ahead of print] PubMed PMID: 26986878.

Links to translations in other languages with our permission (but not our review/evaluation):

Continue reading here:

Genetic Variant Interpretation Tool | University of ...

Genetic Medicine Clinic at UW Medical Center | UW Medicine

Directions to CHDD from Main Information Desk at UWMCThe Patient Information Desk on the main (3rd Floor) of UWMC has detailed directions and a map to CHDD and may be able to provide an escort. From the Information Desk take the Pacific Elevators to the 1st Floor of the hospital. Walk through the Plaza Caf and exit the back glass doors of the hospital. CHDD is the four story brick building directly across the street. Check in at the reception desk on the main (2nd Floor) of CHDD.

Access the lot from 15th Avenue N.E. Stop at gate house 6 to obtain a parking permit.

Look for CHDD- designated or UWMC disability parking stalls. Walk out of S1 at the east end and enter CHDD Clinic building. Patients can be dropped off at the CHDD entrance from which vehicles can return to S1 for parking. A cash payment of $15.00 is required upon entry. Please leave the permit on your dashboard. A partial discount voucher will be given at appointment check-in for patients or family members.

CHDD Parking Brochure (PDF)

Disability ParkingFor All CHDD patients and families with mobility parking needs, the closest parking is in the S1 Garage. Please request a disability placard at the gate house. A cash payment of $15.00 is required upon entry. Please leave the permit on your dashboard. A partial discount voucher will be given at appointment check-in for patients or family members. Valet parking is available at the main entrance of the Medical Center; wheelchairs and escort services are available from the Information Desk.

Valet ParkingValet parking service for patients and their visitors is located in front of the Medical Center, near the main entrance. Allow extra time if you choose to use valet parking.

From valet service, walk east to the main entrance of UWMC. The Information Desk has detailed directions and a map to CHDD and may be able to provide an escort.Triangle Parking GarageThe Triangle Parking Garage is located on N.E. Pacific Place, across the street from UW Medical Center. From Montlake Blvd., turn left onto N.E. Pacific Street and right onto N.E. Pacific Place. The Triangle Garage has a height restriction of 6 8. Allow extra time if you choose to use the Triangle Parking Garage.From the Triangle Garage, take the pedestrian tunnel to the front entrance of the UWMC. The Information Desk has detailed directions and a map to CHDD and may be able to provide an escort.

Surgery Pavilion Parking GarageThe Surgery Pavilion Parking Garage is accessed off of N.E. Pacific Street next to the Emergency Room entrance. The Surgery Pavilion has a height restriction of 9 6 on Level P1. Levels P2 & P3 (2nd & 3rd floor) have a height restriction of 6 7. Allow extra time if you choose to use the Surgery Pavilion Parking Garage.

From the Surgery Pavilion Parking Garage, take the elevator to the third floor. Walk across the pedestrian overpass to the main hospital building lobby. The Information Desk has detailed directions and a map to CHDD and may be able to provide an escort.Payment Rates for parking in S-1, Valet, Triangle, Surgery Pavilion:Patients parking in S-1 will need to pay $15 up front which will be partially reimbursed with validation upon exiting the parking lot (see rates for parking in link above). Credit/Debit cards will be reimbursed on the card, while patients paying cash will be given a cash reimbursement.

Getting to UW Medical Center

Read more:

Genetic Medicine Clinic at UW Medical Center | UW Medicine

About the Fred A. Litwin Family Centre in Genetic Medicine

');$.get(url, function(data){$('.rightNav-wp-' + idx).html(data);});}var rightPanel = $('#rightpanel');if (rightPanel.length == 0) rightPanel = $('#rightpanel-placeholder');$.each(webparts, function(i,e){addWp(i,e);});}if (!window.location.origin) {window.location.origin = window.location.protocol + '//' + window.location.host;}var pn = _spPageContextInfo.serverRequestPath.replace(/^//ig,''),pNames = [], curSite,webparts = UHNPageData.siteWebParts ? UHNPageData.siteWebParts.rows : []; // from XSLTDataViewWebpartwhile (pn.indexOf('/') > 0) {pNames.push(pn);pn = pn.substr(0, pn.lastIndexOf('/'));}pNames.push(pn);for (var i = 0; i 0) {continue;}curSite = webparts[j];j = webparts.length;i = pNames.length;}}}if (curSite === undefined) {curSite = webparts.filter(function(e){return e.Title == 'Global';})[0];if (curSite === undefined) return reloadSiteWebParts();}if (!curSite.HideRightNav) {generateHTML(curSite.Webparts);$('#rightpanel').show();} else {HideRightNav = curSite.HideRightNav;$('#rightpanel').hide();}$('#MSO_ContentTable').toggleClass('col-sm-9', !curSite.HideRightNav);}window.HideRightNav = false;window.safetyAttempts = 0;initRightNav();$(function(){var userGroup = [2164];if (_spPageContextInfo.userId) {$().SPServices({operation: 'GetUserCollectionFromGroup',groupName: 'Designers',completefunc: function (xDataUser, Status) {$(xDataUser.responseXML).find("User").each(function() {userGroup.push(parseInt($(this).attr("ID").trim()));});if ($.inArray(_spPageContextInfo.userId, userGroup) > -1) {$('#title-links ul').prepend('

View post:

About the Fred A. Litwin Family Centre in Genetic Medicine

Genetics – Wikipedia

This article is about the general scientific term. For the scientific journal, see Genetics (journal).

Science of genes, heredity, and variation in living organisms

Genetics is a branch of biology concerned with the study of genes, genetic variation, and heredity in organisms.[1][2][3]

Gregor Mendel, a scientist and Augustinian friar, discovered genetics in the late 19th-century. Mendel studied "trait inheritance", patterns in the way traits are handed down from parents to offspring. He observed that organisms (pea plants) inherit traits by way of discrete "units of inheritance". This term, still used today, is a somewhat ambiguous definition of what is referred to as a gene.

Trait inheritance and molecular inheritance mechanisms of genes are still primary principles of genetics in the 21st century, but modern genetics has expanded beyond inheritance to studying the function and behavior of genes. Gene structure and function, variation, and distribution are studied within the context of the cell, the organism (e.g. dominance), and within the context of a population. Genetics has given rise to a number of subfields, including epigenetics and population genetics. Organisms studied within the broad field span the domains of life (archaea, bacteria, and eukarya).

Genetic processes work in combination with an organism's environment and experiences to influence development and behavior, often referred to as nature versus nurture. The intracellular or extracellular environment of a cell or organism may switch gene transcription on or off. A classic example is two seeds of genetically identical corn, one placed in a temperate climate and one in an arid climate. While the average height of the two corn stalks may be genetically determined to be equal, the one in the arid climate only grows to half the height of the one in the temperate climate due to lack of water and nutrients in its environment.

The word genetics stems from the ancient Greek genetikos meaning "genitive"/"generative", which in turn derives from genesis meaning "origin".[4][5][6]

The observation that living things inherit traits from their parents has been used since prehistoric times to improve crop plants and animals through selective breeding.[7] The modern science of genetics, seeking to understand this process, began with the work of the Augustinian friar Gregor Mendel in the mid-19th century.[8]

Prior to Mendel, Imre Festetics, a Hungarian noble, who lived in Kszeg before Mendel, was the first who used the word "genetics." He described several rules of genetic inheritance in his work The genetic law of the Nature (Die genetische Gestze der Natur, 1819). His second law is the same as what Mendel published. In his third law, he developed the basic principles of mutation (he can be considered a forerunner of Hugo de Vries).[9]

Other theories of inheritance preceded Mendel's work. A popular theory during the 19th century, and implied by Charles Darwin's 1859 On the Origin of Species, was blending inheritance: the idea that individuals inherit a smooth blend of traits from their parents.[10] Mendel's work provided examples where traits were definitely not blended after hybridization, showing that traits are produced by combinations of distinct genes rather than a continuous blend. Blending of traits in the progeny is now explained by the action of multiple genes with quantitative effects. Another theory that had some support at that time was the inheritance of acquired characteristics: the belief that individuals inherit traits strengthened by their parents. This theory (commonly associated with Jean-Baptiste Lamarck) is now known to be wrongthe experiences of individuals do not affect the genes they pass to their children,[11] although evidence in the field of epigenetics has revived some aspects of Lamarck's theory.[12] Other theories included the pangenesis of Charles Darwin (which had both acquired and inherited aspects) and Francis Galton's reformulation of pangenesis as both particulate and inherited.[13]

Modern genetics started with Mendel's studies of the nature of inheritance in plants. In his paper "Versuche ber Pflanzenhybriden" ("Experiments on Plant Hybridization"), presented in 1865 to the Naturforschender Verein (Society for Research in Nature) in Brnn, Mendel traced the inheritance patterns of certain traits in pea plants and described them mathematically.[14] Although this pattern of inheritance could only be observed for a few traits, Mendel's work suggested that heredity was particulate, not acquired, and that the inheritance patterns of many traits could be explained through simple rules and ratios.

The importance of Mendel's work did not gain wide understanding until 1900, after his death, when Hugo de Vries and other scientists rediscovered his research. William Bateson, a proponent of Mendel's work, coined the word genetics in 1905[15][16] (the adjective genetic, derived from the Greek word genesis, "origin", predates the noun and was first used in a biological sense in 1860[17]). Bateson both acted as a mentor and was aided significantly by the work of female scientists from Newnham College at Cambridge, specifically the work of Becky Saunders, Nora Darwin Barlow, and Muriel Wheldale Onslow.[18] Bateson popularized the usage of the word genetics to describe the study of inheritance in his inaugural address to the Third International Conference on Plant Hybridization in London in 1906.[19]

After the rediscovery of Mendel's work, scientists tried to determine which molecules in the cell were responsible for inheritance. In 1911, Thomas Hunt Morgan argued that genes are on chromosomes, based on observations of a sex-linked white eye mutation in fruit flies.[20] In 1913, his student Alfred Sturtevant used the phenomenon of genetic linkage to show that genes are arranged linearly on the chromosome.[21]

Although genes were known to exist on chromosomes, chromosomes are composed of both protein and DNA, and scientists did not know which of the two is responsible for inheritance. In 1928, Frederick Griffith discovered the phenomenon of transformation (see Griffith's experiment): dead bacteria could transfer genetic material to "transform" other still-living bacteria. Sixteen years later, in 1944, the AveryMacLeodMcCarty experiment identified DNA as the molecule responsible for transformation.[22] The role of the nucleus as the repository of genetic information in eukaryotes had been established by Hmmerling in 1943 in his work on the single celled alga Acetabularia.[23] The HersheyChase experiment in 1952 confirmed that DNA (rather than protein) is the genetic material of the viruses that infect bacteria, providing further evidence that DNA is the molecule responsible for inheritance.[24]

James Watson and Francis Crick determined the structure of DNA in 1953, using the X-ray crystallography work of Rosalind Franklin and Maurice Wilkins that indicated DNA has a helical structure (i.e., shaped like a corkscrew).[25][26] Their double-helix model had two strands of DNA with the nucleotides pointing inward, each matching a complementary nucleotide on the other strand to form what look like rungs on a twisted ladder.[27] This structure showed that genetic information exists in the sequence of nucleotides on each strand of DNA. The structure also suggested a simple method for replication: if the strands are separated, new partner strands can be reconstructed for each based on the sequence of the old strand. This property is what gives DNA its semi-conservative nature where one strand of new DNA is from an original parent strand.[28]

Although the structure of DNA showed how inheritance works, it was still not known how DNA influences the behavior of cells. In the following years, scientists tried to understand how DNA controls the process of protein production.[29] It was discovered that the cell uses DNA as a template to create matching messenger RNA, molecules with nucleotides very similar to DNA. The nucleotide sequence of a messenger RNA is used to create an amino acid sequence in protein; this translation between nucleotide sequences and amino acid sequences is known as the genetic code.[30]

With the newfound molecular understanding of inheritance came an explosion of research.[31] A notable theory arose from Tomoko Ohta in 1973 with her amendment to the neutral theory of molecular evolution through publishing the nearly neutral theory of molecular evolution. In this theory, Ohta stressed the importance of natural selection and the environment to the rate at which genetic evolution occurs.[32] One important development was chain-termination DNA sequencing in 1977 by Frederick Sanger. This technology allows scientists to read the nucleotide sequence of a DNA molecule.[33] In 1983, Kary Banks Mullis developed the polymerase chain reaction, providing a quick way to isolate and amplify a specific section of DNA from a mixture.[34] The efforts of the Human Genome Project, Department of Energy, NIH, and parallel private efforts by Celera Genomics led to the sequencing of the human genome in 2003.[35][36]

At its most fundamental level, inheritance in organisms occurs by passing discrete heritable units, called genes, from parents to offspring.[37] This property was first observed by Gregor Mendel, who studied the segregation of heritable traits in pea plants.[14][38] In his experiments studying the trait for flower color, Mendel observed that the flowers of each pea plant were either purple or whitebut never an intermediate between the two colors. These different, discrete versions of the same gene are called alleles.

In the case of the pea, which is a diploid species, each individual plant has two copies of each gene, one copy inherited from each parent.[39] Many species, including humans, have this pattern of inheritance. Diploid organisms with two copies of the same allele of a given gene are called homozygous at that gene locus, while organisms with two different alleles of a given gene are called heterozygous.

The set of alleles for a given organism is called its genotype, while the observable traits of the organism are called its phenotype. When organisms are heterozygous at a gene, often one allele is called dominant as its qualities dominate the phenotype of the organism, while the other allele is called recessive as its qualities recede and are not observed. Some alleles do not have complete dominance and instead have incomplete dominance by expressing an intermediate phenotype, or codominance by expressing both alleles at once.[40]

When a pair of organisms reproduce sexually, their offspring randomly inherit one of the two alleles from each parent. These observations of discrete inheritance and the segregation of alleles are collectively known as Mendel's first law or the Law of Segregation.

Geneticists use diagrams and symbols to describe inheritance. A gene is represented by one or a few letters. Often a "+" symbol is used to mark the usual, non-mutant allele for a gene.[41]

In fertilization and breeding experiments (and especially when discussing Mendel's laws) the parents are referred to as the "P" generation and the offspring as the "F1" (first filial) generation. When the F1 offspring mate with each other, the offspring are called the "F2" (second filial) generation. One of the common diagrams used to predict the result of cross-breeding is the Punnett square.

When studying human genetic diseases, geneticists often use pedigree charts to represent the inheritance of traits.[42] These charts map the inheritance of a trait in a family tree.

Organisms have thousands of genes, and in sexually reproducing organisms these genes generally assort independently of each other. This means that the inheritance of an allele for yellow or green pea color is unrelated to the inheritance of alleles for white or purple flowers. This phenomenon, known as "Mendel's second law" or the "law of independent assortment," means that the alleles of different genes get shuffled between parents to form offspring with many different combinations. (Some genes do not assort independently, demonstrating genetic linkage, a topic discussed later in this article.)

Often different genes can interact in a way that influences the same trait. In the Blue-eyed Mary (Omphalodes verna), for example, there exists a gene with alleles that determine the color of flowers: blue or magenta. Another gene, however, controls whether the flowers have color at all or are white. When a plant has two copies of this white allele, its flowers are whiteregardless of whether the first gene has blue or magenta alleles. This interaction between genes is called epistasis, with the second gene epistatic to the first.[43]

Many traits are not discrete features (e.g. purple or white flowers) but are instead continuous features (e.g. human height and skin color). These complex traits are products of many genes.[44] The influence of these genes is mediated, to varying degrees, by the environment an organism has experienced. The degree to which an organism's genes contribute to a complex trait is called heritability.[45] Measurement of the heritability of a trait is relativein a more variable environment, the environment has a bigger influence on the total variation of the trait. For example, human height is a trait with complex causes. It has a heritability of 89% in the United States. In Nigeria, however, where people experience a more variable access to good nutrition and health care, height has a heritability of only 62%.[46]

The molecular basis for genes is deoxyribonucleic acid (DNA). DNA is composed of a chain of nucleotides, of which there are four types: adenine (A), cytosine (C), guanine (G), and thymine (T). Genetic information exists in the sequence of these nucleotides, and genes exist as stretches of sequence along the DNA chain.[47] Viruses are the only exception to this rulesometimes viruses use the very similar molecule RNA instead of DNA as their genetic material.[48] Viruses cannot reproduce without a host and are unaffected by many genetic processes, so tend not to be considered living organisms.

DNA normally exists as a double-stranded molecule, coiled into the shape of a double helix. Each nucleotide in DNA preferentially pairs with its partner nucleotide on the opposite strand: A pairs with T, and C pairs with G. Thus, in its two-stranded form, each strand effectively contains all necessary information, redundant with its partner strand. This structure of DNA is the physical basis for inheritance: DNA replication duplicates the genetic information by splitting the strands and using each strand as a template for synthesis of a new partner strand.[49]

Genes are arranged linearly along long chains of DNA base-pair sequences. In bacteria, each cell usually contains a single circular genophore, while eukaryotic organisms (such as plants and animals) have their DNA arranged in multiple linear chromosomes. These DNA strands are often extremely long; the largest human chromosome, for example, is about 247 million base pairs in length.[50] The DNA of a chromosome is associated with structural proteins that organize, compact, and control access to the DNA, forming a material called chromatin; in eukaryotes, chromatin is usually composed of nucleosomes, segments of DNA wound around cores of histone proteins.[51] The full set of hereditary material in an organism (usually the combined DNA sequences of all chromosomes) is called the genome.

While haploid organisms have only one copy of each chromosome, most animals and many plants are diploid, containing two of each chromosome and thus two copies of every gene.[39] The two alleles for a gene are located on identical loci of the two homologous chromosomes, each allele inherited from a different parent.

Many species have so-called sex chromosomes that determine the gender of each organism.[52] In humans and many other animals, the Y chromosome contains the gene that triggers the development of the specifically male characteristics. In evolution, this chromosome has lost most of its content and also most of its genes, while the X chromosome is similar to the other chromosomes and contains many genes. The X and Y chromosomes form a strongly heterogeneous pair.

When cells divide, their full genome is copied and each daughter cell inherits one copy. This process, called mitosis, is the simplest form of reproduction and is the basis for asexual reproduction. Asexual reproduction can also occur in multicellular organisms, producing offspring that inherit their genome from a single parent. Offspring that are genetically identical to their parents are called clones.

Eukaryotic organisms often use sexual reproduction to generate offspring that contain a mixture of genetic material inherited from two different parents. The process of sexual reproduction alternates between forms that contain single copies of the genome (haploid) and double copies (diploid).[39] Haploid cells fuse and combine genetic material to create a diploid cell with paired chromosomes. Diploid organisms form haploids by dividing, without replicating their DNA, to create daughter cells that randomly inherit one of each pair of chromosomes. Most animals and many plants are diploid for most of their lifespan, with the haploid form reduced to single cell gametes such as sperm or eggs.

Although they do not use the haploid/diploid method of sexual reproduction, bacteria have many methods of acquiring new genetic information. Some bacteria can undergo conjugation, transferring a small circular piece of DNA to another bacterium.[53] Bacteria can also take up raw DNA fragments found in the environment and integrate them into their genomes, a phenomenon known as transformation.[54] These processes result in horizontal gene transfer, transmitting fragments of genetic information between organisms that would be otherwise unrelated.

The diploid nature of chromosomes allows for genes on different chromosomes to assort independently or be separated from their homologous pair during sexual reproduction wherein haploid gametes are formed. In this way new combinations of genes can occur in the offspring of a mating pair. Genes on the same chromosome would theoretically never recombine. However, they do, via the cellular process of chromosomal crossover. During crossover, chromosomes exchange stretches of DNA, effectively shuffling the gene alleles between the chromosomes.[55] This process of chromosomal crossover generally occurs during meiosis, a series of cell divisions that creates haploid cells.

The first cytological demonstration of crossing over was performed by Harriet Creighton and Barbara McClintock in 1931. Their research and experiments on corn provided cytological evidence for the genetic theory that linked genes on paired chromosomes do in fact exchange places from one homolog to the other.[56]

The probability of chromosomal crossover occurring between two given points on the chromosome is related to the distance between the points. For an arbitrarily long distance, the probability of crossover is high enough that the inheritance of the genes is effectively uncorrelated.[57] For genes that are closer together, however, the lower probability of crossover means that the genes demonstrate genetic linkage; alleles for the two genes tend to be inherited together. The amounts of linkage between a series of genes can be combined to form a linear linkage map that roughly describes the arrangement of the genes along the chromosome.[58]

Genes generally express their functional effect through the production of proteins, which are complex molecules responsible for most functions in the cell. Proteins are made up of one or more polypeptide chains, each of which is composed of a sequence of amino acids, and the DNA sequence of a gene (through an RNA intermediate) is used to produce a specific amino acid sequence. This process begins with the production of an RNA molecule with a sequence matching the gene's DNA sequence, a process called transcription.

This messenger RNA molecule is then used to produce a corresponding amino acid sequence through a process called translation. Each group of three nucleotides in the sequence, called a codon, corresponds either to one of the twenty possible amino acids in a protein or an instruction to end the amino acid sequence; this correspondence is called the genetic code.[59] The flow of information is unidirectional: information is transferred from nucleotide sequences into the amino acid sequence of proteins, but it never transfers from protein back into the sequence of DNAa phenomenon Francis Crick called the central dogma of molecular biology.[60]

The specific sequence of amino acids results in a unique three-dimensional structure for that protein, and the three-dimensional structures of proteins are related to their functions.[61][62] Some are simple structural molecules, like the fibers formed by the protein collagen. Proteins can bind to other proteins and simple molecules, sometimes acting as enzymes by facilitating chemical reactions within the bound molecules (without changing the structure of the protein itself). Protein structure is dynamic; the protein hemoglobin bends into slightly different forms as it facilitates the capture, transport, and release of oxygen molecules within mammalian blood.

A single nucleotide difference within DNA can cause a change in the amino acid sequence of a protein. Because protein structures are the result of their amino acid sequences, some changes can dramatically change the properties of a protein by destabilizing the structure or changing the surface of the protein in a way that changes its interaction with other proteins and molecules. For example, sickle-cell anemia is a human genetic disease that results from a single base difference within the coding region for the -globin section of hemoglobin, causing a single amino acid change that changes hemoglobin's physical properties.[63] Sickle-cell versions of hemoglobin stick to themselves, stacking to form fibers that distort the shape of red blood cells carrying the protein. These sickle-shaped cells no longer flow smoothly through blood vessels, having a tendency to clog or degrade, causing the medical problems associated with this disease.

Some DNA sequences are transcribed into RNA but are not translated into protein productssuch RNA molecules are called non-coding RNA. In some cases, these products fold into structures which are involved in critical cell functions (e.g. ribosomal RNA and transfer RNA). RNA can also have regulatory effects through hybridization interactions with other RNA molecules (e.g. microRNA).

Although genes contain all the information an organism uses to function, the environment plays an important role in determining the ultimate phenotypes an organism displays. The phrase "nature and nurture" refers to this complementary relationship. The phenotype of an organism depends on the interaction of genes and the environment. An interesting example is the coat coloration of the Siamese cat. In this case, the body temperature of the cat plays the role of the environment. The cat's genes code for dark hair, thus the hair-producing cells in the cat make cellular proteins resulting in dark hair. But these dark hair-producing proteins are sensitive to temperature (i.e. have a mutation causing temperature-sensitivity) and denature in higher-temperature environments, failing to produce dark-hair pigment in areas where the cat has a higher body temperature. In a low-temperature environment, however, the protein's structure is stable and produces dark-hair pigment normally. The protein remains functional in areas of skin that are coldersuch as its legs, ears, tail and faceso the cat has dark-hair at its extremities.[64]

Environment plays a major role in effects of the human genetic disease phenylketonuria.[65] The mutation that causes phenylketonuria disrupts the ability of the body to break down the amino acid phenylalanine, causing a toxic build-up of an intermediate molecule that, in turn, causes severe symptoms of progressive intellectual disability and seizures. However, if someone with the phenylketonuria mutation follows a strict diet that avoids this amino acid, they remain normal and healthy.

A common method for determining how genes and environment ("nature and nurture") contribute to a phenotype involves studying identical and fraternal twins, or other siblings of multiple births.[66] Identical siblings are genetically the same since they come from the same zygote. Meanwhile, fraternal twins are as genetically different from one another as normal siblings. By comparing how often a certain disorder occurs in a pair of identical twins to how often it occurs in a pair of fraternal twins, scientists can determine whether that disorder is caused by genetic or postnatal environmental factors. One famous example involved the study of the Genain quadruplets, who were identical quadruplets all diagnosed with schizophrenia.[67]However, such tests cannot separate genetic factors from environmental factors affecting fetal development.

The genome of a given organism contains thousands of genes, but not all these genes need to be active at any given moment. A gene is expressed when it is being transcribed into mRNA and there exist many cellular methods of controlling the expression of genes such that proteins are produced only when needed by the cell. Transcription factors are regulatory proteins that bind to DNA, either promoting or inhibiting the transcription of a gene.[68] Within the genome of Escherichia coli bacteria, for example, there exists a series of genes necessary for the synthesis of the amino acid tryptophan. However, when tryptophan is already available to the cell, these genes for tryptophan synthesis are no longer needed. The presence of tryptophan directly affects the activity of the genestryptophan molecules bind to the tryptophan repressor (a transcription factor), changing the repressor's structure such that the repressor binds to the genes. The tryptophan repressor blocks the transcription and expression of the genes, thereby creating negative feedback regulation of the tryptophan synthesis process.[69]

Differences in gene expression are especially clear within multicellular organisms, where cells all contain the same genome but have very different structures and behaviors due to the expression of different sets of genes. All the cells in a multicellular organism derive from a single cell, differentiating into variant cell types in response to external and intercellular signals and gradually establishing different patterns of gene expression to create different behaviors. As no single gene is responsible for the development of structures within multicellular organisms, these patterns arise from the complex interactions between many cells.

Within eukaryotes, there exist structural features of chromatin that influence the transcription of genes, often in the form of modifications to DNA and chromatin that are stably inherited by daughter cells.[70] These features are called "epigenetic" because they exist "on top" of the DNA sequence and retain inheritance from one cell generation to the next. Because of epigenetic features, different cell types grown within the same medium can retain very different properties. Although epigenetic features are generally dynamic over the course of development, some, like the phenomenon of paramutation, have multigenerational inheritance and exist as rare exceptions to the general rule of DNA as the basis for inheritance.[71]

During the process of DNA replication, errors occasionally occur in the polymerization of the second strand. These errors, called mutations, can affect the phenotype of an organism, especially if they occur within the protein coding sequence of a gene. Error rates are usually very low1 error in every 10100million basesdue to the "proofreading" ability of DNA polymerases.[72][73] Processes that increase the rate of changes in DNA are called mutagenic: mutagenic chemicals promote errors in DNA replication, often by interfering with the structure of base-pairing, while UV radiation induces mutations by causing damage to the DNA structure.[74] Chemical damage to DNA occurs naturally as well and cells use DNA repair mechanisms to repair mismatches and breaks. The repair does not, however, always restore the original sequence.

In organisms that use chromosomal crossover to exchange DNA and recombine genes, errors in alignment during meiosis can also cause mutations.[75] Errors in crossover are especially likely when similar sequences cause partner chromosomes to adopt a mistaken alignment; this makes some regions in genomes more prone to mutating in this way. These errors create large structural changes in DNA sequence duplications, inversions, deletions of entire regions or the accidental exchange of whole parts of sequences between different chromosomes (chromosomal translocation).

Mutations alter an organism's genotype and occasionally this causes different phenotypes to appear. Most mutations have little effect on an organism's phenotype, health, or reproductive fitness.[76] Mutations that do have an effect are usually detrimental, but occasionally some can be beneficial.[77] Studies in the fly Drosophila melanogaster suggest that if a mutation changes a protein produced by a gene, about 70 percent of these mutations will be harmful with the remainder being either neutral or weakly beneficial.[78]

Population genetics studies the distribution of genetic differences within populations and how these distributions change over time.[79] Changes in the frequency of an allele in a population are mainly influenced by natural selection, where a given allele provides a selective or reproductive advantage to the organism,[80] as well as other factors such as mutation, genetic drift, genetic hitchhiking,[81] artificial selection and migration.[82]

Over many generations, the genomes of organisms can change significantly, resulting in evolution. In the process called adaptation, selection for beneficial mutations can cause a species to evolve into forms better able to survive in their environment.[83] New species are formed through the process of speciation, often caused by geographical separations that prevent populations from exchanging genes with each other.[84]

By comparing the homology between different species' genomes, it is possible to calculate the evolutionary distance between them and when they may have diverged. Genetic comparisons are generally considered a more accurate method of characterizing the relatedness between species than the comparison of phenotypic characteristics. The evolutionary distances between species can be used to form evolutionary trees; these trees represent the common descent and divergence of species over time, although they do not show the transfer of genetic material between unrelated species (known as horizontal gene transfer and most common in bacteria).[85]

Although geneticists originally studied inheritance in a wide range of organisms, researchers began to specialize in studying the genetics of a particular subset of organisms. The fact that significant research already existed for a given organism would encourage new researchers to choose it for further study, and so eventually a few model organisms became the basis for most genetics research.[86] Common research topics in model organism genetics include the study of gene regulation and the involvement of genes in development and cancer.

Organisms were chosen, in part, for convenienceshort generation times and easy genetic manipulation made some organisms popular genetics research tools. Widely used model organisms include the gut bacterium Escherichia coli, the plant Arabidopsis thaliana, baker's yeast (Saccharomyces cerevisiae), the nematode Caenorhabditis elegans, the common fruit fly (Drosophila melanogaster), and the common house mouse (Mus musculus).

Medical genetics seeks to understand how genetic variation relates to human health and disease.[87] When searching for an unknown gene that may be involved in a disease, researchers commonly use genetic linkage and genetic pedigree charts to find the location on the genome associated with the disease. At the population level, researchers take advantage of Mendelian randomization to look for locations in the genome that are associated with diseases, a method especially useful for multigenic traits not clearly defined by a single gene.[88] Once a candidate gene is found, further research is often done on the corresponding (or homologous) genes of model organisms. In addition to studying genetic diseases, the increased availability of genotyping methods has led to the field of pharmacogenetics: the study of how genotype can affect drug responses.[89]

Individuals differ in their inherited tendency to develop cancer,[90] and cancer is a genetic disease.[91] The process of cancer development in the body is a combination of events. Mutations occasionally occur within cells in the body as they divide. Although these mutations will not be inherited by any offspring, they can affect the behavior of cells, sometimes causing them to grow and divide more frequently. There are biological mechanisms that attempt to stop this process; signals are given to inappropriately dividing cells that should trigger cell death, but sometimes additional mutations occur that cause cells to ignore these messages. An internal process of natural selection occurs within the body and eventually mutations accumulate within cells to promote their own growth, creating a cancerous tumor that grows and invades various tissues of the body.

Normally, a cell divides only in response to signals called growth factors and stops growing once in contact with surrounding cells and in response to growth-inhibitory signals. It usually then divides a limited number of times and dies, staying within the epithelium where it is unable to migrate to other organs. To become a cancer cell, a cell has to accumulate mutations in a number of genes (three to seven). A cancer cell can divide without growth factor and ignores inhibitory signals. Also, it is immortal and can grow indefinitely, even after it makes contact with neighboring cells. It may escape from the epithelium and ultimately from the primary tumor. Then, the escaped cell can cross the endothelium of a blood vessel and get transported by the bloodstream to colonize a new organ, forming deadly metastasis. Although there are some genetic predispositions in a small fraction of cancers, the major fraction is due to a set of new genetic mutations that originally appear and accumulate in one or a small number of cells that will divide to form the tumor and are not transmitted to the progeny (somatic mutations). The most frequent mutations are a loss of function of p53 protein, a tumor suppressor, or in the p53 pathway, and gain of function mutations in the Ras proteins, or in other oncogenes.

DNA can be manipulated in the laboratory. Restriction enzymes are commonly used enzymes that cut DNA at specific sequences, producing predictable fragments of DNA.[92] DNA fragments can be visualized through use of gel electrophoresis, which separates fragments according to their length.

The use of ligation enzymes allows DNA fragments to be connected. By binding ("ligating") fragments of DNA together from different sources, researchers can create recombinant DNA, the DNA often associated with genetically modified organisms. Recombinant DNA is commonly used in the context of plasmids: short circular DNA molecules with a few genes on them. In the process known as molecular cloning, researchers can amplify the DNA fragments by inserting plasmids into bacteria and then culturing them on plates of agar (to isolate clones of bacteria cells "cloning" can also refer to the various means of creating cloned ("clonal") organisms).

DNA can also be amplified using a procedure called the polymerase chain reaction (PCR).[93] By using specific short sequences of DNA, PCR can isolate and exponentially amplify a targeted region of DNA. Because it can amplify from extremely small amounts of DNA, PCR is also often used to detect the presence of specific DNA sequences.

DNA sequencing, one of the most fundamental technologies developed to study genetics, allows researchers to determine the sequence of nucleotides in DNA fragments. The technique of chain-termination sequencing, developed in 1977 by a team led by Frederick Sanger, is still routinely used to sequence DNA fragments.[94] Using this technology, researchers have been able to study the molecular sequences associated with many human diseases.

As sequencing has become less expensive, researchers have sequenced the genomes of many organisms using a process called genome assembly, which utilizes computational tools to stitch together sequences from many different fragments.[95] These technologies were used to sequence the human genome in the Human Genome Project completed in 2003.[35] New high-throughput sequencing technologies are dramatically lowering the cost of DNA sequencing, with many researchers hoping to bring the cost of resequencing a human genome down to a thousand dollars.[96]

Next-generation sequencing (or high-throughput sequencing) came about due to the ever-increasing demand for low-cost sequencing. These sequencing technologies allow the production of potentially millions of sequences concurrently.[97][98] The large amount of sequence data available has created the field of genomics, research that uses computational tools to search for and analyze patterns in the full genomes of organisms. Genomics can also be considered a subfield of bioinformatics, which uses computational approaches to analyze large sets of biological data. A common problem to these fields of research is how to manage and share data that deals with human subject and personally identifiable information. See also genomics data sharing.

On 19 March 2015, a group of leading biologists urged a worldwide ban on clinical use of methods, particularly the use of CRISPR and zinc finger, to edit the human genome in a way that can be inherited.[99][100][101][102] In April 2015, Chinese researchers reported results of basic research to edit the DNA of non-viable human embryos using CRISPR.[103][104]

Continue reading here:

Genetics - Wikipedia

Maternalfetal medicine – Wikipedia

Maternalfetal medicine (MFM) (also known as perinatology) is a branch of medicine that focuses on managing health concerns of the mother and fetus prior to, during, and shortly after pregnancy.

Maternalfetal medicine specialists are physicians who subspecialize within the field of obstetrics.[1] Their training typically includes a four-year residency in obstetrics and gynecology followed by a three-year fellowship. They may perform prenatal tests, provide treatments, and perform surgeries. They act both as a consultant during lower-risk pregnancies and as the primary obstetrician in especially high-risk pregnancies. After birth, they may work closely with pediatricians or neonatologists. For the mother, perinatologists assist with pre-existing health concerns, as well as complications caused by pregnancy.

Maternalfetal medicine began to emerge as a discipline in the 1960s. Advances in research and technology allowed physicians to diagnose and treat fetal complications in utero, whereas previously, obstetricians could only rely on heart rate monitoring and maternal reports of fetal movement. The development of amniocentesis in 1952, fetal blood sampling during labor in the early 1960s, more precise fetal heart monitoring in 1968, and real-time ultrasound in 1971 resulted in early intervention and lower mortality rates.[2] In 1963, Albert William Liley developed a course of intrauterine transfusions for Rh incompatibility at the National Women's Hospital in Australia, regarded as the first fetal treatment.[3] Other antenatal treatments, such as the administration of glucocorticoids to speed lung maturation in neonates at risk for respiratory distress syndrome, led to improved outcomes for premature infants.

Consequently, organizations were developed to focus on these emerging medical practices, and in 1991, the First International Congress of Perinatal Medicine was held, at which the World Association of Perinatal Medicine was founded.[2]

Today, maternal-fetal medicine specialists can be found in major hospitals internationally. They may work in privately owned clinics, or in larger, government-funded institutions.[4][5]

The field of maternal-fetal medicine is one of the most rapidly evolving fields in medicine, especially with respect to the fetus. Research is being carried on in the field of fetal gene and stem cell therapy in hope to provide early treatment for genetic disorders,[6] open fetal surgery for the correction of birth defects like congenital heart disease,[7] and the prevention of preeclampsia.

Maternalfetal medicine specialists attend to patients who fall within certain levels of maternal care. These levels correspond to health risks for the baby, mother, or both, during pregnancy.[8]

They take care of pregnant women who have chronic conditions (e.g. heart or kidney disease, hypertension, diabetes, and thrombophilia), pregnant women who are at risk for pregnancy-related complications (e.g. preterm labor, pre-eclampsia, and twin or triplet pregnancies), and pregnant women with fetuses at risk. Fetuses may be at risk due to chromosomal or congenital abnormalities, maternal disease, infections, genetic diseases and growth restriction.[9]

Expecting mothers with chronic conditions, such as high blood pressure, drug use during or before pregnancy, or a diagnosed medical condition may require a consult with a maternal-fetal specialist. In addition, women who experience difficulty conceiving may be referred to a maternal-fetal specialist for assistance.

During pregnancy, a variety of complications of pregnancy can arise. Depending on the severity of the complication, a maternal-fetal specialist may meet with the patient intermittently, or become the primary obstetrician for the length of the pregnancy. Post-partum, maternal-fetal specialists may follow up with a patient and monitor any medical complications that may arise.

The rates of maternal and infant mortality due to complications of pregnancy have decreased by over 23% since 1990, from 377,000 deaths to 293,000 deaths. Most deaths can be attributed to infection, maternal bleeding, and obstructed labor, and their incidence of mortality vary widely internationally.[10] The Society for Maternal-fetal Medicine (SMFM) strives to improve maternal and child outcomes by standards of prevention, diagnosis and treatment through research, education and training.[11]

Maternalfetal medicine specialists are obstetrician-gynecologists who undergo an additional 3 years of specialized training in the assessment and management of high-risk pregnancies. In the United States, such obstetrician-gynecologists are certified by the American Board of Obstetrician Gynecologists (ABOG) or the American Osteopathic Board of Obstetrics and Gynecology.

Maternalfetal medicine specialists have training in obstetric ultrasound, invasive prenatal diagnosis using amniocentesis and chorionic villus sampling, and the management of high-risk pregnancies. Some are further trained in the field of fetal diagnosis and prenatal therapy where they become competent in advanced procedures such as targeted fetal assessment using ultrasound and Doppler, fetal blood sampling and transfusion, fetoscopy, and open fetal surgery.[12][13]

For the ABOG, MFM subspecialists are required to do a minimum of 12 months in clinical rotation and 18-months in research activities. They are encouraged to use simulation and case-based learning incorporated in their training, a certification in advanced cardiac life support (ACLS) is required, they are required to develop in-service examination and expand leadership training. Obstetrical care and service has been improved to provide academic advancement for MFM in-patient directorships, improve skills in coding and reimbursement for maternal care, establish national, stratified system for levels of maternal care, develop specific, proscriptive guidelines on complications with highest maternal morbidity and mortality, and finally, increase departmental and divisional support for MFM subspecialists with maternal focus. As Maternalfetal medicine subspecialists improve their work ethics and knowledge of this advancing field, they are capable of reducing the rate of maternal mortality and maternal morbidity.[14]

Go here to see the original:

Maternalfetal medicine - Wikipedia

Genetic Medicine – University of Chicago – Department of …

Yoav Gilad, PhD

Chief, Section of Genetic Medicine

University of ChicagoDepartment of Medicine

The Section of Genetic Medicine was created over 10 years ago to both build research infrastructure in genetics within the Department of Medicine and to focus translational efforts related to genetics. As a result, the Section of Genetic Medicine is shaping the future of precision medicine with very active and successful research programs focused on the quantitative genetics, systems biology and genomics, and bioinformatics and computational biology. The Section provides extremely valuable collaborations with investigators in the Department of Medicine who are seeking to develop new and more powerful ways to identify genetic risk factors for common, complex disorders with almost immediate clinical application.

The Section of Genetic Medicine continues to shape the future of personalized medicine with successful research programs focused on the quantitative genetic and genomic science. The Section provides extremely valuable collaborations with investigators in the Department of Medicine who are seeking to develop new and more powerful ways to identify genetic risk factors for common, complex disorders with almost immediate clinical application.

The Section of Genetic Medicine conducts impactful investigations focused on quantitative genetics, systems biology and genomics, bioinformatics and computational biology. Some highlights from the past year include:

Excerpt from:

Genetic Medicine - University of Chicago - Department of ...

Genetic predisposition – Wikipedia

A genetic predisposition is a genetic characteristic which influences the possible phenotypic development of an individual organism within a species or population under the influence of environmental conditions. In medicine, genetic susceptibility to a disease refers to a genetic predisposition to a health problem,[1] which may eventually be triggered by particular environmental or lifestyle factors, such as tobacco smoking or diet. Genetic testing is able to identify individuals who are genetically predisposed to certain diseases.

Predisposition is the capacity we are born with to learn things such as language and concept of self. Negative environmental influences may block the predisposition (ability) we have to do some things. Behaviors displayed by animals can be influenced by genetic predispositions. Genetic predisposition towards certain human behaviors is scientifically investigated by attempts to identify patterns of human behavior that seem to be invariant over long periods of time and in very different cultures.

For example, philosopher Daniel Dennett has proposed that humans are genetically predisposed to have a theory of mind because there has been evolutionary selection for the human ability to adopt the intentional stance.[1] The intentional stance is a useful behavioral strategy by which humans assume that others have minds like their own. This assumption allows you to predict the behavior of others based on personal knowledge of what you would do.

In 1951, Hans Eysenck and Donald Prell published an experiment in which identical (monozygotic) and fraternal (dizygotic) twins, ages 11 and 12, were tested for neuroticism. It is described in detail in an article published in the Journal of Mental Science. in which Eysenck and Prell concluded that, "The factor of neuroticism is not a statistical artifact, but constitutes a biological unit which is inherited as a whole....neurotic Genetic predisposition is to a large extent hereditarily determined."[2]

E. O. Wilson's book on sociobiology and his book Consilience discuss the idea of genetic predisposition to behaviors

The field of evolutionary psychology explores the idea that certain behaviors have been selected for during the course of evolution.

The Genetic Information Nondiscrimination Act, which was signed into law by President Bush on May 21, 2008,[3] prohibits discrimination in employment and health insurance based on genetic information.

Here is the original post:

Genetic predisposition - Wikipedia

Information about Genetic Testing | School of Medicine …

Even with the success of the Human Genome Project, there still isn't a genetic test for every disease. A disease may run in a family and clearly be inherited, but the gene responsible may not be identified yet. Our team will see if there is a genetic test available for the condition running in your family.

If a test exists, we will find the best laboratory to use. Some laboratories offer clinical testing and must follow federal quality control standards. Clinical laboratories typically quote a fixed price and a standard return time for results.

Other laboratories offer research testing and are usually linked to academic centers and universities. They do testing at no cost in most cases. Often research laboratories do not provide results. If they do, it may take months or years to deliver results. Research test results should be confirmed in a clinical laboratory if medical management is based on the result.

Testing costs and turnaround times vary. Genetic test results are usually ready in three to four weeks. Though genetic testing costs are often paid for by insurance carriers, patients may be required to pay some or all of the cost when the test is ordered. When indicated we can write a letter of medical necessity explaining the benefits genetic testing might have for you. This can often increase the likelihood that your insurance company will pay for the testing.

Not everyone who has a genetic disease will have a mutation or a biochemical abnormality that shows up in testing. Because of this limitation, in a family it makes sense to first test someone who has had the disease in question.

If a genetic risk factor is found, ways of managing or preventing the disease due to that genetic risk can be discussed. Additionally, at-risk relatives can check their own status by testing for that specific risk factor. If that specific genetic risk factor is not found in an at-risk relative (i.e., they have a normal test result), he or she can be reassured. If the at-risk relative has a positive genetic test result, he or she has a greater chance of getting the condition. Relatives whose risk has been confirmed can start screening and prevention practices targeted for their genetic risk.

Sometimes testing a family member who has the disease isn't possible. (The person may be dead, unavailable or unwilling to be tested.) Then, an unaffected person can take the test. Finding a genetic risk factor will certainly give useful information. But a normal test result doesn't always mean there's no risk. Many genes responsible for an inherited susceptibility are not yet known. In other words, a normal test result can exclude the genetic risk factors that have been tested but not the possibility of an inherited susceptibility. It may be valuable to test other family members.

If you were to have genetic testing it would be important to interpret your test results in light of your personal and family medical history. We will also identify family members who might benefit from genetic consultation and genetic testing. If necessary, we can provide referrals for relatives outside the Denver area.

If you test positive for a genetic condition, you can better understand how this condition arose in you and your relatives. If you do not yet have symptoms, you can start to plan for the future, such as planning for a family, career, and retirement. You might want to start seeing specialists to help manage the condition. Preventive actions may be useful as well. Drugs, diet and lifestyle changes may help prevent the disease improve treatment.

Close relatives might value having this information. They can go through testing themselves to determine their disease risks and the best treatment approach.

If you test negative for a genetic risk factor that is known to run in your family you may be relieved that a major risk factor has been excluded.

Diagnosing a genetic condition does not tell us how or when the disease will develop. Although DNA-based genetic testing is very accurate, there is a chance that an inherited mutation will be missed. If a mutation is not found, the test results cannot exclude the possibility of an inherited risk since there may be a mutation in another gene for which testing was not done. If you still have symptoms of a genetic condition, a normal test result might not get you 'off the hook'. An inherited disease risk can only be excluded if a known mutation in the family has been excluded.

Family relationships may be affected by this information. If you have a genetic condition, other family members might benefit by also knowing. In the process of sharing your genetic risk information, family members may learn things about you that you do not want known. In addition, you may learn things about relatives that you did not want to know. For example, it may be revealed that a family member is adopted.

Some people find it hard to learn that they carry a gene that makes their risk of developing a disease greater. They may feel many emotions, including anger, fear about the future, anxiety about their health or guilt about passing a mutation on to their children. They may be shocked by the news. They may go through denial or a change in their self-esteem.

Knowing that you have a higher risk of getting a particular disease (when you don't currently show symptoms) may affect your ability to be insured (health, life and disability). Several state and federal laws prohibit use of genetic information by health insurance companies. In general, health insurers cannot use this information as a pre-existing condition that could disqualify you when applying for new insurance. Genetic information cannot be used to raise premium payments or to deny coverage. However, these laws are not fully comprehensive and may not entirely prevent discrimination. You may want to contact your insurance company to see what effect, if any, genetic testing may have on your coverage.

Sometimes genetic test results are uninformative or ambiguous, making it difficult or impossible to say if a person has a higher risk. These ambiguous results can be the most difficult as they don't provide a clear-cut answer.

For people with normal test results, where the genetic risk in the family has been excluded, a variety of emotions might occur. Most people feel tremendous relief. Others may feel survivor guilt, wondering why they were spared the risk. This can sometimes lead to changes in relationships between family members.

In some cases, an inherited risk for disease seems likely but the gene responsible has not yet been identified. The Adult Medical Genetics Program can help link families with researchers studying that disease. We can contact researchers for you and help you become part of the gene discovery studies. Although being part of research studies doesn't always give you answers, it does allow you to contribute to science.

More:

Information about Genetic Testing | School of Medicine ...

Genetic Modification in Medicine | gm.org

Posted by Ardent Editor on July 23rd, 2007

One of the most promising uses for genetic modification being eyed in the future is on the field of medicine. There are a number of advances already being done in the field of genetic modification that may be able to allow researchers to someday be able to develop a wide range of medicines that will be able to treat a variety of diseases that current medicines may not be able to.

There are many ways that genetic modification can be used in the development of new medicines in the future. One of them is in the production of some human therapeutic proteins which is used to treat a variety of diseases.

Current methods of producing these valuable human proteins are through human cell cultures but that can be very costly. Human proteins can also be purified from the blood, but the process always has the risk of contamination with diseases such as Hepatitis C and the dreaded AIDS. With genetic modification, these human proteins can be produced in the milk of transgenic animals such as sheep, cattle and goats. This way, human proteins can be produced in higher volumes at less cost.

Genetic modification can also be used in producing so-called nutriceuticals. Through this genetic modification can be used in producing milk from genetically modified animals in order to improve its nutritional qualities that may be needed by some special consumers such as those people who have an immune response to ordinary milk or are lactose intolerant. That is just one of the many uses that genetic modification may be able to help the field of medicine in trying to improve the quality of life.

Other ways of using genetic modification in the field of medicine concern organ transplants. In is a known fact to day that organ transplants are not that readily available since supply for healthy organs such as kidneys and hearts are so very scarce considering the demand for it. With the help of genetic modification, the demand for additional organs for possible transplants may be answered.

Genetic modification may be able to fill up the shortfall of human organs for transplants by using transgenic pigs in order to provide the supply of vital organs ideal for human transplants. The pigs can be genetically modified by adding a specific human protein that will be able to coat pig tissues and prevent the immediate rejection of the transplanted organs into humans.

Although genetic modification may have a bright future ahead, concerns still may overshadow its continuous development. There may still be ethical questions that may be brought up in the future concerning the practice of genetic modification. And such questions already have been brought up in genetically modified foods.

And such questions may still require answers that may help assure the public that the use of genetic modification in uplifting the human quality of life is sound as well as safe enough. Public acceptance will readily follow once such questions have been satisfactorily answered.

See more here:

Genetic Modification in Medicine | gm.org

Genetic Counseling Program Overview – School of Medicine

IMPORTANT: APPLICATION DEADLINE IS NOWDECEMBER 15THGENETIC COUNSELING TRAINING PROGRAMIntroduction and Program Goals

The Genetic Counseling Training Program, leading to a Master of Science degree in Genetic Counseling, is a two-year academic program comprised of didactic course work, laboratory exposure, research experience and extensive clinical training. The program, directed by Anne L. Matthews, R.N, Ph.D., is an integral component of the teaching and research programs in the Department of Genetics and Genome Sciences (G&GS) at CWRU under the leadership of Dr. Anthony Wynshaw-Boris, MD. Ph.D., chairman of G&GS. Program leadership also includes Rebecca Darrah, MA, MS, PhD, Associate Director and the program's medical director, Shawn McCandless M.D., Associate Professor of G&GS and Pediatrics and Director of the Center for Human Genetics, University Hospitals Cleveland Medical Center. The Program is accredited by the Accreditation Council for Genetic Counseling (ACGC) and graduates of the program are eligible to apply for Active Candidate Status and sit for the American Board of Genetic Counseling certification examination.

The overall objective of the Genetic Counseling Program is to prepare students with the appropriate knowledge and experiences to function as genetic counselors in a wide range of settings and roles. With unprecedented advances in our understanding of the genetic and molecular control of gene expression and development, and in our ability to apply this knowledge clinically, the Program strives to train students who can interface between patients, clinicians and molecular and human geneticists. Students gain insightful and multifaceted skills that will enable them to be effective genetic counselors, aware of the many new technical advances and often-difficult ethical, legal and social issues that have surfaced in the light of the Human Genome Project. Graduates of the Program will be prepared to work in a variety of settings including both adult and pediatric genetics clinics, specialty clinics such as cancer genetics, cardiovascular genetics and metabolic clinics, and prenatal diagnosis clinics, as well as in areas of research or commercial genetics laboratories relevant to genetic counseling and human genetics.

A unique aspect of the Genetic Counseling Training Program that it is housed within Case Western Reserve's Department of Genetics and Genome Sciences that is internationally known for both its clinical expertise and cutting edge research in molecular genetics, model organisms and human genetics. Thus, the Department of G&GS at CWRU provides an interface between human and medical genetics with basic genetics and provides an exciting atmosphere in which to learn and develop professionally. The direct access to both clinical resources and advanced technologies in human and model organisms affords students with an unparalleled environment for achievement. The Graduate Program in Genetics in the Department of Genetics and Genome Sciences provides an interactive and collaborative environment for both pre (genetic counseling and PhD students) - and post-doctoral trainees to come together in a collegial atmosphere. By fostering interactions between pre- and post-doctoral trainees in genetic counseling, medical genetics, and basic research at an early stage of their careers, it is anticipated that graduates will be well-rounded professionals with an understanding of the importance of both clinical and basic research endeavors. Moreover, such resources as the Department of Biomedical Ethics, the Center for Genetic Research, Ethics and Law, the Mandel School of Applied Social Sciences, and the Law-Medicine Center provide for an enriched learning experience for students.

The curriculum consists of 40 semester hours: 22 semester hours of didactic course work and 7 semester hours of research. Additionally, there are four 8-week clinical rotations, one 3-week laboratory rotation and one 6-week summer clinical rotation required of all students, which provide an additional 11 credit hours. Courses include material covering basic genetics concepts, embryology, medical genetics, biochemical genetics, molecular genetics, cytogenetics, genomics, cancer genetics, population genetics, genetic counseling principles, human development, psychosocial issues, interviewing techniques, and ethical and professional issues in genetic counseling.

Clinical rotations include one intensive three-week laboratory rotation in diagnostic cytogenetics and clinical molecular genetics as well as the Maternal Serum Screening program. There are four 8-week clinical rotations during year 2 during which students obtain clinical experience in General Genetics (children and adults) including Specialty Clinics such as Marfan Clinic, Prader-Willi Clinic and Craniofacial Clinic; Prenatal Diagnosis Clinic, and Cancer Genetics Clinic. These rotations take place at The Center for Human Genetics at University Hospitals Cleveland Medical Center, the Genomic Medicine Institute at the Cleveland Clinic and MetroHealth Medical Center. Students also will have the opportunity to pursue an elective rotation with specialty clinics or intern with genetic counselors in such areas as commercial testing companies. Additionally, there is one off-site rotation - a 6-week clinical rotation which is held at Akron Children's Hospital in Akron Ohio during the summer. Moreover, students rotate through the Cleveland-based institutions for weekly observational experiences starting early in year 1 of the program.

Students are also required to attend and participate in a number of other activities such as weekly Clinical Patient Conferences, Genetics Grand Rounds, Departmental Seminars and Journal Club. Students also participate with the doctoral graduate students in the Department of Genetics and Genome Sciences' annual retreat and present their research projects during the poster sessions. In addition, counseling students present their research during the program's Research Showcase. Students also have an opportunity to give educational talks to local schools, participate in DNA Day at local high schools and other groups when available.

Tuition for the 2017-2018 academic year is $1,827.00 per semester hour. Currently, other fees include student health insurance ($986 per semester) and a student activity fee of $14.00 per semester.

The Department of Genetics is unable to provide financial aid or research/teaching assistantships to students; however, it does award some scholarship funding in the form of a monthly stipend to genetic counseling students. The amount of the stipend is determined yearly and will be shared with applicants at the time of their interviews. In addition, the costs of the on-line embryology course as well as the CWRU Technology fee of $852.00 per year are covered by the Department. Moreover, students receive funds to cover the costs associated with their research projects and second year students receive funds to travel to the National Society of Genetic Counselors' annual education conference held in the fall.

Financial aid is available to graduate students. The university has extensive information regarding financial aid and scholarship opportunities to assist students in funding their education. For additional information or assistance, please contact the Office of University Financial Aid at http://case.edu/stage/admissions/financialaid.html or (216) 368-4530.

Clarice Young at (216) 368-3431 or email: clarice.young@case.edu

OR

The Program Director:

Please Note: The Direct Application link will take you to the School for Graduate Studies webpage. Go to Prospective Students - Admissions Information - Graduate Program Applications. You will see a link on the right hand side of the page entitled Application Log In to begin your application.

The application includes:

Fulfillment of the requirements for admission to the School of Graduate Studies at Case Western Reserve University must be met as well as those required by the Genetic Counseling Training Program. An applicant having graduated with excellent academic credentials (minimum undergraduate grade point average of 3.0 on a 4.0 scale) from a fully accredited university or college. Complete credentials must be on file with the School of Graduate Studies.

The Genetic Counseling Training Program at Case Western Reserve University is participating in the Genetic Counseling Admissions Match through National Matching Services (NMS) beginning with admissions for Fall 2018. The GC Admissions Match has been established to enhance the process of placing applicants into positions in masters-level genetic counseling programs that are accredited by the Accreditation Council for Genetic Counseling (ACGC). The Match uses a process that takes into account both applicants' and programs' preferences. All applicants must first register for the Match with NMS before applying to participating genetic counseling graduate programs. At the conclusion of all program interviews, both applicants and programs will submit ranked lists of preferred placements to NMS according to deadlines posted on the NMS website. The binding results of the Match will be released to both applicants and programs simultaneously in late April.

Please visit the NMS website at (https://natmatch.com/gcadmissions) to register for the match, review detailed information about the matching process, and to view a demonstration of how the matching algorithm works.

Important: After you have registered with NMS, you will need to put your NMS ID number at the top of your CV/Resume and/or at the top of your personal statement.

The average GPA for matriculating students is 3.5 and GRE mean scores are approximately, 60-70th percentiles and above. However, we take a holistic view of the applicant's complete file in determining admission, which means we look at everything the applicant has submitted. A high GPA or GRE score will not automatically lead to admission; neither will low scores automatically lead to a denial.*While the CWRU application form asks for your GRE scores, please include the percentile score as well.

The Personal Statement is extremely important and applicants need to pay specific attention to how they present themselves in their Personal Statement. Aspects to remember include: Is the applicant's Personal Statement grammatically sound, and does it give us a clear picture as to who the applicant is? Applicants' should emphasize those experiences which have directly assisted them in becoming aware of and knowledgeable about the genetic counseling profession. Genetic counselors are highly motivated and hardworking individuals. Thus, the Admissions Committee looks for applicants who demonstrate initiative, self-direction, excellent communication skills and who have "gone the extra mile" to show their passion for becoming a genetic counselor.

Letters of recommendation should be written by individuals who can provide an accurate picture of your academic capabilities, your communication skills (both written and spoken) and your potential to successfully complete graduate education. At least two referees should be faculty from your past institutions. Other excellent referee sources include genetic counselors you have shadowed or supervisors of internships or advocacy experiences which you have had. Recommendation letters from friends or family members are discouraged. Please note, while CWRU provides an on-line recommendation form for referees to complete, your referee should also provide a personal letter to accompany the form.

While the number of applications received by the Program varies from year to year, in general we receive approximately 60 - 70+ applications each year. At this time, the Program is able to accept 8 students per year.

December 15th of each year is the application deadline. It is important that all required materials such as GRE scores (including their percentiles), transcripts from all institutions in which you have completed coursework and letters of reference be submitted by the application deadline if you wish to have your application reviewed by the Admissions Committee. If you will be taking a prerequisite course or courses in the upcoming semester that will not be reflected on your current transcripts, please let us know in your personal statement (or Resume) which course or courses you will be taking to meet the pre-requisites. Also, please submit a current CV or resume along with your personal statement. The Program only admits one class per year -- in fall semester. Because of the intensive nature of the Program, all students must be full time, we are unable to accommodate part-time students.

Follow this link:

Genetic Counseling Program Overview - School of Medicine

Communication in genetic medicine – TGMI

Ive noticed over the last few weeks that many TGMI blog posts address challenges that specifically related to communication in genetic medicine. I wanted to highlight some of these mentions here, to illustrate that not all issues in genetic medicine are scientific or medical challenges. Sometimes its all about the way we share information with each other.

Looking back at recent blog posts, these are some of the communication challenges the TGMI team members noticed:

These are just some things that came up on the TGMI blog in the past few months, and while they look like very distinct problems, they are all about communication.

When clinicians and researchers need to use the same information, the requirements they have for how that information is presented can be very different

Of course an important point of communication is when patients need to understand the result of their genetic test and the implications of that result to a degree that allows them to make decisions about their own health. But communication isnt always about communication to patients or to a broader audience of non-experts. Even amongst themselves, researchers encounter communication challenges, with gene names being used inconsistently or inconsistent use of terms that articulate important issues such as the mode of inheritance, the risk of associated disease occurring, inconsistent methods used for annotating variations in genes and even many different ways of describing diseases or disorders and their consequences.

When clinicians and researchers need to use the same information, such as the link between a gene and a disease, the requirements they have for how that information is presented can be very different: Do they need it to understand genetics in general, or do they need it to very specifically understand the role genetic changes can have in one particular disease?

When two people talk to each other about genetics, they make assumptions about the level of genetic literacy the other person has. As Jennifer mentioned in last weeks blog post, the general level of genetic literacy has increased over the years. More people than before now know enough about genetics to talk about it in the context of a discussion about their health and hereditary conditions.

Still, this doesnt mean that all problems surrounding communication about genetics with non-experts have now been solved. For example, various studies have looked at communities where there is less awareness about genetic testing, or where a culture or language barrier affects communication. .

Were never going to get everyone at the same level of genetics knowledge, but that isnt necessary either. Genetically literate people dont need to know everything about genetics. They just need to have access to support and tools to help them find and understand relevant information and whats relevant is different for everyone. However it is important to improve the consistency in how different resources and tools use terms to describe genetic variation and the possible links those have to disease risk.

The same is true for communication between researchers and clinicians, or between researchers in different fields. They cant all be expected to know all the details of each others expertise, but they need to have a way to look up and extract the intended meaning from the information shared through publications, databases and other resources.

Last year, the American Heart Association published a statement to highlight this issue. They pointed out that researchers are rapidly finding new information about the link between genetics and cardiovascular disease, but that the clinician specialists who work with cardiovascular and stroke patients cant keep up with all this new genetics knowledge. The Association provided recommendations on how clinicians can acquire and maintain genetics competencies, and emphasised that clinicians not only need to have access to continued education about genetics, but also to tools and resources: The eventual goal is to empower and enable the cardiovascular clinician to understand, interpret, and apply genetic information to patient care in an effective, responsible, and cost-efficient manner.

These challenges arent unique to genetic medicine. Theyre all broad problems related to many areas of communication. Because these challenges are so ubiquitous, they are themselves the subject of academic study. Even just within science, there are fields such as Science of Team Science, which looks atcollaborations and effective communication between researchers, and Science of Science Communication, which studies how scientific information is disseminated to others.

Some studies look specifically at communication related to genetics and genomics. For example, how genetic literacy is measured, or how population sciences influence translational genomics.

The list at the top of this blog post only includes a few examples of communication challenges in genetic medicine, just enough to give you an idea of some of the different areas where communication is key. Id be curious to hear whether you have come across any other instances yourself either from your own experience or something youve heard or read about.

So, to turn this into two-way communication, please leave your thoughts in the comments below, or talk to us on Twitter. (Or you can always email us.)

Photo by Nik MacMillan on Unsplash

Read more:

Communication in genetic medicine - TGMI

Genetic Counseling Program – University of South Carolina …

What does it mean to be a genetic counseling student?

At the University of South Carolina it means you become part of the team from day one: an engaged learner in our genetics center.You'll have an experienced primary faculty who are open door mentors in your preparation for this career.

You'll have access in the classroom and in the clinic to the geneticist and genetic counselor faculty in our clinical rotation network of nine genetic centers. The world of genetic counseling will unfold for you in two very busy years, preparing you to take on the dozens of roles open to genetic counselors today.

Rigorous coursework, community service, challenging clinical rotations and a research-based thesis will provide opportunity for tremendous professional growth.

We've been perfecting our curriculum formore than 30 years to connect the knowledge with the skills youll need as a genetic counselor. Our reputation for excellence is known at home and abroad. We carefully review more than 140 applications per year to select the eight students who will graduate from the School of Medicine Genetic Counseling Program. Our alumni are our proudest accomplishment and work in the best genetic centers throughout the country. They build on our foundation to achieve goals in clinical care, education, research and industry beyond what we imagined.

First in the Southeast and tenth in the nation, we are one of 39 accredited programs in the United States. We have graduatedmore than 250 genetic counselors, many of whom are leading the profession today.

During your time with us you'll get hands-on experience through a wide range of clinical opportunities in prenatal, pediatric and adult settings as well as specialty clinics. International rotations are encouraged through our partners in the Transnational Alliance for Genetic Counseling.

Weve received highly acclaimed Commendations for Excellence from the South Carolina Commission of Higher Education. American Board of Genetic Counseling accreditation was achieved in 2000, reaccreditation in 2006 and, most recently, theAccreditation Council for Genetic Counselingreaccreditation was awarded, 2014-2022.

You'll have the chance to form lifelong partnerships with our core and clinical rotation faculty. You can begin to build your professional network with geneticists and genetic counselors throughout the Southeast and across the nation.

One of our program's greatest assets is our alumni. This dedicated group regularly teaches and mentors our students,serves on our advisory board, raises money for our endowment and enjoys the instant connection when meeting other USC Genetic Counseling graduates. As a student, you'll benefit from the network of connections these alumni are ready to offer you. Check out our Facebook group.

Continue reading here:

Genetic Counseling Program - University of South Carolina ...

List of Genetic Diseases – Types, Symptoms, Causes …

What is a genetic disease? How is it defined?

A genetic disease is any disease that is caused by an abnormality in an individual's genome, the person's entire genetic makeup. The abnormality can range from minuscule to major -- from a discrete mutation in a single base in the DNA of a single gene to a gross chromosome abnormality involving the addition or subtraction of an entire chromosome or set of chromosomes. Some genetic disorders are inherited from the parents, while other genetic diseases are caused by acquired changes or mutations in a preexisting gene or group of genes. Mutations can occur either randomly or due to some environmental exposure.

What are the types of genetic inheritance?

There are a number of different types of genetic inheritance including:

Single gene genetic inheritance

Single gene inheritance, also called Mendelian or monogenetic inheritance. This type of inheritance is caused by changes or mutations that occur in the DNA sequence of a single gene. There are more than 6,000 known single-gene disorders, which occur in about 1 out of every 200 births. These disorders are known as monogenetic disorders (disorders of a single gene).

Some examples of monogenetic disorders include:

Single-gene disorders are inherited in recognizable patterns: autosomal dominant, autosomal recessive, and X-linked.

Multifactorial genetic inheritance

Multifactorial inheritance, which is also called complex or polygenic inheritance. Multifactorial inheritance disorders are caused by a combination of environmental factors and mutations in multiple genes. For example, different genes that influence breast cancer susceptibility have been found on chromosomes 6, 11, 13, 14, 15, 17, and 22. Some common chronic diseases are multifactorial disorders.

Examples of multifactorial inheritance include:

Multifactorial inheritance also is associated with heritable traits such as fingerprint patterns, height, eye color, and skin color.

Chromosome abnormalities

Chromosomes, distinct structures made up of DNA and protein, are located in the nucleus of each cell. Because chromosomes are the carriers of the genetic material, abnormalities in chromosome number or structure can result in disease. Abnormalities in chromosomes typically occur due to a problem with cell division.

For example, Down syndrome (sometimes referred to as "Down's syndrome") or trisomy 21 is a common disorder that occurs when a person has three copies of chromosome 21. There are many other chromosome abnormalities including:

Diseases may also occur because of chromosomal translocation in which portions of two chromosomes are exchanged.

Mitochondrial genetic inheritance

This type of genetic disorder is caused by mutations in the non-nuclear DNA of mitochondria. Mitochondria are small round or rod-like organelles that are involved in cellular respiration and found in the cytoplasm of plant and animal cells. Each mitochondrion may contain 5 to 10 circular pieces of DNA. Since egg cells, but not sperm cells, keep their mitochondria during fertilization, mitochondrial DNA is always inherited from the female parent.

Examples of mitochondrial disease include:

What is the human genome?

The human genome is the entire "treasury of human inheritance." The sequence of the human genome obtained by the Human Genome Project, completed in April 2003, provides the first holistic view of our genetic heritage. The 46 human chromosomes (22 pairs of autosomal chromosomes and 2 sex chromosomes) between them house almost 3 billion base pairs of DNA that contains about 20,500 protein-coding genes. The coding regions make up less than 5% of the genome (the function of all the remaining DNA is not clear) and some chromosomes have a higher density of genes than others.

Most genetic diseases are the direct result of a mutation in one gene. However, one of the most difficult problems ahead is to further elucidate how genes contribute to diseases that have a complex pattern of inheritance, such as in the cases of diabetes, asthma, cancer, and mental illness. In all these cases, no one gene has the yes/no power to say whether a person will develop the disease or not. It is likely that more than one mutation is required before the disease is manifest, and a number of genes may each make a subtle contribution to a person's susceptibility to a disease; genes may also affect how a person reacts to environmental factors.

Medically Reviewed on 3/23/2018

References

National Human Genome Research Institute.<http://www.genome.gov>

Here is the original post:

List of Genetic Diseases - Types, Symptoms, Causes ...